A detailed history of Bank Of America Corp transactions in Compass Pathways PLC stock. As of the latest transaction made, Bank Of America Corp holds 47,283 shares of CMPS stock, worth $403,796. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,283
Previous 42,656 10.85%
Holding current value
$403,796
Previous $364,000 10.71%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
4,627 Added 10.85%
47,283 $403,000
Q2 2024

Aug 14, 2024

BUY
N/A
26,568 Added 165.14%
42,656 $364,000
Q1 2024

May 15, 2024

SELL
N/A
-5,123 Reduced 24.15%
16,088 $137,000
Q4 2023

Feb 14, 2024

SELL
N/A
-6,774 Reduced 24.21%
21,211 $181,000
Q2 2023

Aug 14, 2023

SELL
$7.79 - $10.69 $1,230 - $1,689
-158 Reduced 0.56%
27,985 $238,000
Q1 2023

May 12, 2023

BUY
$7.32 - $10.85 $40,025 - $59,327
5,468 Added 24.11%
28,143 $279,000
Q4 2022

Feb 10, 2023

SELL
$7.84 - $11.68 $148,928 - $221,873
-18,996 Reduced 45.59%
22,675 $182,000
Q3 2022

Nov 14, 2022

SELL
$10.73 - $20.07 $98,812 - $184,824
-9,209 Reduced 18.1%
41,671 $447,000
Q2 2022

Aug 12, 2022

BUY
$6.76 - $14.18 $187,204 - $392,686
27,693 Added 119.43%
50,880 $550,000
Q1 2022

May 16, 2022

SELL
$11.13 - $23.04 $539,237 - $1.12 Million
-48,449 Reduced 67.63%
23,187 $299,000
Q4 2021

Feb 08, 2022

BUY
$21.81 - $48.96 $1.39 Million - $3.13 Million
63,920 Added 828.41%
71,636 $1.58 Million
Q3 2021

Nov 15, 2021

SELL
$29.03 - $38.62 $1.94 Million - $2.58 Million
-66,683 Reduced 89.63%
7,716 $230,000
Q2 2021

Sep 13, 2021

BUY
$32.29 - $39.68 $2.4 Million - $2.95 Million
74,399 New
74,399 $2.84 Million

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.